Cargando…

Clopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity

BACKGROUND: Despite the proven benefits of clopidogrel combined aspirin therapy for coronary artery disease (CAD), CAD patients with metabolic syndrome (MS) still tend to have coronary thrombotic events. We aimed to investigate the influence of metabolic risk factors on the efficacy of clopidogrel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhao-Ke, Wang, Jing-Jing, Wang, Ting, Zhu, Shen-Shen, Chen, Xi-Ling, Liu, Chao, Zhang, Wei-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554785/
https://www.ncbi.nlm.nih.gov/pubmed/26347447
http://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.009